SELLAS Life Sciences Group Revenue

Biotechnology Research • Manhattan, New York, United States • 11-20 Employees

SELLAS Life Sciences Group revenue & valuation

Annual revenue	$1,000,000
Revenue per employee	$59,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$3,200,000
Total funding	No funding

Key Contacts at SELLAS Life Sciences Group

Nancy D. Ecklund

Senior Director, Human Resources

Lisa Pantano

Director Quality Control And Assurance

Angela Pettit

Associate Director, Finance

James Dean

Senior Director, Clinical Operations

Company overview

Headquarters	7 Times Square, Suite 2503, New York, NY 10036, US
Phone number	+16462005278
Websites	sellaslifesciences.com sellaslife.com
NAICS	541714
SIC	283
Keywords	Oncology, Biopharma, Immunotherapies, Late Stage Clinical Trials, Hematologic Oncology
Founded	2012
Employees	11-20
Socials

SELLAS Life Sciences Group Email Formats

SELLAS Life Sciences Group uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@sellaslife.com), used 66.7% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@sellaslife.com	66.7%
{first initial}{last name}	jdoe@sellaslife.com	33.3%

About SELLAS Life Sciences Group

We are a late-stage clinical biopharmaceutical company focused on developing novel therapies for a broad range of cancer indications. SELLAS’ lead product candidate, galinpepimut-S (GPS), is licensed from Memorial Sloan Kettering Cancer Center and targets the Wilms Tumor 1 (WT1) protein, which is present in an array of tumor types. Our second product candidate, GFH009, is a highly selective small molecule cyclin-dependent kinase 9 (CDK9) inhibitor licensed from GenFleet Therapeutics, which we hold the exclusive rights to for further development and commercialization of the asset across all therapeutic and diagnostic uses outside of greater China. GPS and GFH009 have potential as monotherapies, or in combination with other therapies, to address a broad spectrum of hematologic malignancies and solid tumor indications.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Director

Entry

Manager

Employees by Department

SELLAS Life Sciences Group has 9 employees across 5 departments.

Departments

Number of employees

Funding Data

SELLAS Life Sciences Group has never raised funding before.

SELLAS Life Sciences Group Tech Stack

Discover the technologies and tools that power SELLAS Life Sciences Group's digital infrastructure, from frameworks to analytics platforms.

jQuery CDN

CDN

reCAPTCHA

Security

WP Rocket

Caching

jQuery UI

JavaScript libraries

Google Maps

Maps

Hello Elementor

WordPress themes

Elementor

Page builders

jQuery Migrate

JavaScript libraries

jQuery

JavaScript libraries

PHP

Programming languages

HSTS

Security

WordPress

Blogs

Frequently asked questions

SELLAS Life Sciences Group is located in Manhattan, New York, US.

You can reach SELLAS Life Sciences Group at +16462005278.

SELLAS Life Sciences Group generates an estimated annual revenue of $1,000,000. This revenue figure reflects the company's market position and business performance in its industry.

SELLAS Life Sciences Group has an estimated valuation of $3,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

SELLAS Life Sciences Group was founded in 2012, making it 14 years old. The company has established itself as a significant player in its industry over this time.

SELLAS Life Sciences Group has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contacts at SELLAS Life Sciences Group

Nancy D. Ecklund

Senior Director, Human Resources

Lisa Pantano

Director Quality Control And Assurance

Angela Pettit

Associate Director, Finance

James Dean

Senior Director, Clinical Operations

4.8

40,000 users